Imatinib and chromosome analysis abnormal Patient Reports February 11, 2012

Imatinib Side Effects Report #4591312-X
Imatinib side effect was reported by a Health Professional from on Feb 18, 2005. Male patient, 67 years of age, was diagnosed with myeloproliferative disorder and was treated with Imatinib. After drug was administered, patient experienced the following side effects: biopsy bone marrow abnormal, blast cell crisis, chills, chromosome analysis abnormal, haemoglobin decreased, neutropenia, night sweats, pleural effusion. Imatinib dosage: 100 MG/DAY. Patient died.

Imatinib Side Effects Report #4582904-2
Imatinib side effect was reported by a Physician from on Feb 04, 2005. Female patient, 76 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: bone marrow depression, chromosome analysis abnormal, neutropenia, pancytopenia, thrombocytopenia, trisomy 8. Imatinib dosage: 600 MG TO 200 MG/DAY. Patient recovered.

Imatinib Side Effects Report #4617250-1
Imatinib side effect was reported by a Health Professional from on Mar 17, 2005. Male patient, 74 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: chromosome analysis abnormal, myelodysplastic syndrome. Imatinib dosage: unknown. Patient recovered.

Imatinib Side Effects Report #4582920-0
Imatinib side effect was reported by a Physician from on Feb 04, 2005. Male patient, 71 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: bone marrow depression, chromosome analysis abnormal, neutropenia, pancytopenia, thrombocytopenia. Imatinib dosage: 600 MG/DAY. Patient recovered.


Imatinib Side Effects Report #4617249-5
Imatinib side effect was reported by a Health Professional from on Mar 17, 2005. Female patient, 67 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: chromosome analysis abnormal, myelodysplastic syndrome. Imatinib dosage: unknown. Patient recovered.

Imatinib Side Effects Report #4582905-4
Imatinib side effect was reported by a Physician from on Feb 04, 2005. Female patient, 66 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: bone marrow depression, chromosome analysis abnormal, neutropenia, pancytopenia, thrombocytopenia, trisomy 8. Imatinib dosage: 400 MG/DAY. Patient recovered.

Imatinib Side Effects Report #4832999-3
Imatinib side effect was reported by a Health Professional from AUSTRALIA on Nov 09, 2005. Male patient, 63 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: chromosome analysis abnormal, fungal sepsis, leukaemia cutis, rash maculo-papular. Imatinib dosage: 400 MG/D. Patient died.

Imatinib Side Effects Report #5813749-0
Imatinib side effect was reported by a Health Professional from CZECH REPUBLIC on July 07, 2008. Female patient, 58 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: chromosome analysis abnormal, infection . Imatinib dosage: unknown. During the same period patient was treated with DASATINIB. Patient died.

Imatinib Side Effects Report #4593844-7
Imatinib side effect was reported by a Consumer or non-health professional from on Feb 22, 2005. Female patient, 58 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: blast crisis in myelogenous leukaemia, chromosome analysis abnormal, chronic myeloid leukaemia, leukopenia. Imatinib dosage: 400 MG/DAY. Patient died.


Imatinib Side Effects Report #5375885-5
Imatinib side effect was reported by a Health Professional from AUSTRALIA on June 27, 2007. Female patient, 56 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, bone marrow failure, chromosome analysis abnormal, chronic myeloid leukaemia, dysplasia, macrocytosis, malignant neoplasm progression, myelodysplastic syndrome, myeloid maturation arrest. Imatinib dosage: 400 MG/D. Patient died.

Imatinib Side Effects Report #5430651-7
Imatinib side effect was reported by a Consumer or non-health professional from SPAIN on Aug 08, 2007. Male patient, 55 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: anaemia, chromosome analysis abnormal, erythropoiesis abnormal, myelodysplastic syndrome, neutropenia. Imatinib dosage: 400 MG/DAY. During the same period patient was treated with IMATINIB MESYLATE, INTERFERON ALFA. Patient recovered.

Imatinib Side Effects Report #6098032-3
Imatinib side effect was reported by a Health Professional from ITALY on Feb 17, 2009. Female patient, 55 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: chromosome analysis abnormal, chronic myeloid leukaemia, diarrhoea, electrocardiogram abnormal, fluid retention, gene mutation identification test positive, glucose tolerance impaired, haematotoxicity, nausea . Imatinib dosage: 400 MG/DAY. During the same period patient was treated with IMATINIB MESYLATE, NILOTINIB, DASATINIB, HYDROXYUREA. Patient recovered.

Imatinib Side Effects Report #4883596-5
Imatinib side effect was reported by a Physician from SPAIN on Jan 06, 2006. Male patient, 55 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: anaemia, chromosome analysis abnormal, erythropoiesis abnormal, myelodysplastic syndrome, neutropenia. Imatinib dosage: 400 MG/DAY. Patient recovered.

Imatinib Side Effects Report #4582912-1
Imatinib side effect was reported by a Physician from on Feb 04, 2005. Female patient, 53 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: bone marrow depression, chromosome analysis abnormal, neutropenia, pancytopenia, thrombocytopenia, trisomy 8. Imatinib dosage: 400 MG/DAY. Patient recovered.


Imatinib Side Effects Report #5129360-3
Imatinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 06, 2006. Female patient, 51 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blast cell proliferation, chromosome analysis abnormal, myelodysplastic syndrome, pancytopenia. Imatinib dosage: 400 MG/DAY. Patient died.

Imatinib Side Effects Report #4883570-9
Imatinib side effect was reported by a Physician from UNITED STATES on Jan 06, 2006. Female patient, 51 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: blast cell proliferation, chromosome analysis abnormal, myelodysplastic syndrome, pancytopenia. Imatinib dosage: 400 MG/DAY. Patient recovered.

Imatinib Side Effects Report #4582919-4
Imatinib side effect was reported by a Physician from on Feb 04, 2005. Female patient, 43 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: bone marrow depression, chromosome analysis abnormal, neutropenia, pancytopenia, thrombocytopenia, trisomy 8. Imatinib dosage: 400 MG/DAY. Patient recovered.

Imatinib Side Effects Report #5391966-4
Imatinib side effect was reported by a Health Professional from UNITED STATES on July 13, 2007. Female patient, 42 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, chromosome analysis abnormal, complications of bone marrow transplant. Imatinib dosage: 400 MG/D. During the same period patient was treated with IMATINIB MESYLATE. Patient died.

Imatinib Side Effects Report #5874478-0
Imatinib side effect was reported by a Health Professional from JAPAN on May 30, 2008. Male patient, 41 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: chromosome analysis abnormal, haemoglobin decreased, myelodysplastic syndrome, white blood cell count decreased. Imatinib dosage: 600 MG/DAY. During the same period patient was treated with IMATINIB MESYLATE. Patient recovered.


Imatinib Side Effects Report #5953217-9
Imatinib side effect was reported by a Health Professional from CZECH REPUBLIC on Nov 05, 2008. Female patient, 41 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, chromosome analysis abnormal, clonal evolution, pancytopenia, stem cell transplant. Imatinib dosage: unknown. Patient recovered.

Imatinib Side Effects Report #5604034-0
Imatinib side effect was reported by a Health Professional from JAPAN on Jan 14, 2008. Male patient, 35 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: blast crisis in myelogenous leukaemia, chromosome analysis abnormal, disseminated intravascular coagulation, fibrin d dimer increased, fibrin degradation products, haemorrhagic diathesis, hypovolaemic shock, malignant neoplasm progression, petechiae. Imatinib dosage: 600 MG/D. During the same period patient was treated with DANAPAROID. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #6047996-2
Imatinib side effect was reported by a Health Professional from FRANCE on Jan 20, 2009. Female patient, 21 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: blast crisis in myelogenous leukaemia, chromosome analysis abnormal. Imatinib dosage: 400 MG/DAY. During the same period patient was treated with IMATINIB MESYLATE, NILOTINIB, DASATINIB. Patient died on 11/01/2006.

Imatinib Side Effects Report #4865944-5
Imatinib side effect was reported by a Consumer or non-health professional from JAPAN on Dec 21, 2005. Female patient, 72 years of age, was diagnosed with blast crisis in myelogenous leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: blood calcium increased, blood lactate dehydrogenase increased, bone pain, chromosome analysis abnormal, fatigue, malignant neoplasm progression, pancytopenia, parathyroid hormone-related protein increased, platelet count decreased. Imatinib dosage: 400 MG/D. Patient died on 05/31/2002.

Imatinib Side Effects Report #5693247-8
Imatinib side effect was reported by a Health Professional from UNITED STATES on Mar 25, 2008. Female patient, 62 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: chromosome analysis abnormal, cytogenetic abnormality, fluid retention, malignant neoplasm progression, monocytosis, myelodysplastic syndrome, pancytopenia. Imatinib dosage: 600 MG/D. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, DEXAMETHASONE, PREDNISONE. Patient recovered.


Imatinib Side Effects Report #5823157-4
Imatinib side effect was reported by a Health Professional from UNITED STATES on July 17, 2008. Female patient, 62 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: chromosome analysis abnormal, cytogenetic abnormality, fluid retention, malignant neoplasm progression, monocytosis, myelodysplastic syndrome, pancytopenia. Imatinib dosage: 600 MG/D. During the same period patient was treated with IMATINIB MESYLATE, IMATINIB MESYLATE, CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, DEXAMETHASONE, PREDNISONE. Patient recovered.